Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Adamson

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Clinical Pharmacology and Therapeutics|June 14, 2023
Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence EpilepsyKana Mizuno, Edmund V Capparelli, Tsuyoshi Fukuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium reportJulia Glade Bender, Susan M Blaney, Scott Borinstein, et al.
Neurology|May 31, 2013
Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcomeDennis Dlugos, Shlomo Shinnar, Avital Cnaan, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2008
Pharmacokinetics and safety of caspofungin in older infants and toddlersMichael Neely, Hasan S Jafri, Nita Seibel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.
Pediatric Blood & Cancer|June 20, 2020
Pediatric cancer research: Surviving COVID-19Jeffery J Auletta, Peter C Adamson, Jonathan E Agin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Clinical Pharmacology and Therapeutics|June 14, 2023
Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence EpilepsyKana Mizuno, Edmund V Capparelli, Tsuyoshi Fukuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium reportJulia Glade Bender, Susan M Blaney, Scott Borinstein, et al.
Neurology|May 31, 2013
Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcomeDennis Dlugos, Shlomo Shinnar, Avital Cnaan, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2008
Pharmacokinetics and safety of caspofungin in older infants and toddlersMichael Neely, Hasan S Jafri, Nita Seibel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.
Pediatric Blood & Cancer|June 20, 2020
Pediatric cancer research: Surviving COVID-19Jeffery J Auletta, Peter C Adamson, Jonathan E Agin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.
Pageof 18